Skip to main content

Arcturus Therapeutics: Q1 Earnings Snapshot

SAN DIEGO (AP) — SAN DIEGO (AP) — Arcturus Therapeutics (ARCT) on Thursday reported a loss of $27 million in its first quarter.

The San Diego-based company said it had a loss of 95 cents per share.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.14 per share.

The pharmaceutical company posted revenue of $2.1 million in the period, missing Street forecasts. Five analysts surveyed by Zacks expected $7.9 million.

Arcturus Therapeutics shares have risen 45% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $8.90, a drop of 19% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARCT at https://www.zacks.com/ap/ARCT

One Tech Tip: What to know about flying with lithium ion portable battery chargers

Jetting off soon for summer travels? If you're planning on bringing an extra battery charger for your phone or other devices, be aware of the latest rules when taking one on a flight. Rechargeable lithium-ion portable battery chargers, also known as power banks, come in protective enclosures of various shapes and sizes. They're a handy and popular way for getting more juice when you're on the move. But after a spate of smoke or fire incidents, U.S. and international aviation authorities have issued new guidelines and airlines have tightened up rules for passengers. Here's a guide on flying with power banks.
Read Next Story

Related News

Knicks take 1-0 lead into game 2 against the Spurs

Beijing bans 4 New Zealand lawmakers from entering China because they visited Taiwan

Police warn families of Tiananmen crackdown dead not to visit graves on 37th anniversary